Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00012727
Status:
COMPLETED
Last Update Posted:
2015-04-07
First Post:
2001-03-14
Brief Title:
Matching Outcomes and Costs in Substance AbusePsychiatric Treatment
Sponsor:
US Department of Veterans Affairs
Organization:
VA Office of Research and Development
Study Overview
Official Title:
Matching Outcomes and Costs in Substance AbusePsychiatric Treatment
Status:
COMPLETED
Status Verified Date:
2005-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This projects goal is to improve the quality of care and reduce treatment costs for veterans with substance abuse and psychiatric problems
Detailed Description:
Background
This projects goal is to improve the quality of care and reduce treatment costs for veterans with substance abuse and psychiatric problems
Objectives
This project is evaluating a patient-treatment matching strategy to improve residential treatment for substance abuse patients with psychiatric disorders Its immediate objective is to examine whether the matching strategy results in more effective and cost-effective treatment in VA programs We hypothesize that patients with severe clinical problems will have better outcomes when they are matched to service-intensive programs patients with moderate problems will have better outcomes when they are matched to programs having a lower intensity of services For both patient groups community treatment should prove to be more cost-effective than hospital treatment
Methods
The project utilized a stratified randomized design We paired each of three VA hospital programs that treat dual diagnosis patients and are high on intensity with a nearby high-intensity community residential facility CRF that contracts with the VA We also paired four VA hospital and four CRFs that are low on intensity Veterans who applied for substance abuse treatment at VA facilities were randomly assigned to either the VA hospital or CRF Patient assessments have been conducted at intake N230 discharge and a 4-month follow-up Primary outcomes are patients severity of substance abuse and psychiatric problems Secondary outcomes are patients functional status and their VA and non-VA health care utilization and its costs
Status
Completed
This projects goal is to improve the quality of care and reduce treatment costs for veterans with substance abuse and psychiatric problems
Objectives
This project is evaluating a patient-treatment matching strategy to improve residential treatment for substance abuse patients with psychiatric disorders Its immediate objective is to examine whether the matching strategy results in more effective and cost-effective treatment in VA programs We hypothesize that patients with severe clinical problems will have better outcomes when they are matched to service-intensive programs patients with moderate problems will have better outcomes when they are matched to programs having a lower intensity of services For both patient groups community treatment should prove to be more cost-effective than hospital treatment
Methods
The project utilized a stratified randomized design We paired each of three VA hospital programs that treat dual diagnosis patients and are high on intensity with a nearby high-intensity community residential facility CRF that contracts with the VA We also paired four VA hospital and four CRFs that are low on intensity Veterans who applied for substance abuse treatment at VA facilities were randomly assigned to either the VA hospital or CRF Patient assessments have been conducted at intake N230 discharge and a 4-month follow-up Primary outcomes are patients severity of substance abuse and psychiatric problems Secondary outcomes are patients functional status and their VA and non-VA health care utilization and its costs
Status
Completed
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None